https://nxtin.health/2026/10/23/citius-altius-robotius-neura-robotics-and-tum-open-robogym-in-munich/ 2026-10-23T08:34:15Z NXTin health en Citius, Altius, Robotius! NEURA Robotics and TUM open RoboGym in Munich 2026-10-23T08:05:41Z Blog https://nxtin.health/2026/10/23/slovakia-launches-e68-million-mission-health-programme-to-improve-patient-care/ 2026-10-23T07:51:25Z NXTin health en Slovakia launches €68 million Mission Health programme to improve patient care 2026-10-23T07:51:23Z Blog https://nxtin.health/2026/10/23/miracells-smart-m-cell-featured-in-clinical-study-demonstrating-improved-pain-and-knee-function-in-severe-osteoarthritis/ 2026-10-23T07:47:38Z NXTin health en Miracell's SMART M-CELL featured in clinical study demonstrating improved pain and knee function in severe osteoarthritis 2026-10-23T05:02:00Z Blog https://nxtin.health/2026/10/22/sanofi-breaks-ground-on-new-state-of-the-art-insulin-manufacturing-facility-in-germany/ 2026-10-22T17:56:00Z NXTin health en Sanofi breaks ground on new state-of-the-art insulin manufacturing facility in Germany 2026-10-22T17:55:57Z Blog https://nxtin.health/2026/10/22/georgiamune-and-menarini-group-enter-exclusive-global-license-and-collaboration-agreement-for-gim-621-a-first-in-class-oral-immuno-oncology-agent/ 2026-10-22T16:16:06Z NXTin health en Georgiamune and Menarini group enter exclusive global license and collaboration agreement for GIM-621, a first-in-class oral immuno-oncology agent 2026-10-22T16:09:04Z Blog https://nxtin.health/2026/10/22/latvia-strengthens-preparedness-for-mass-casualty-incidents/ 2026-10-22T15:46:17Z NXTin health en Latvia strengthens preparedness for mass-casualty incidents 2026-10-22T15:46:15Z Blog https://nxtin.health/2026/10/22/in-exceptional-cases-hospitals-and-pharmacies-will-be-allowed-to-purchase-medicines-directly-from-foreign-manufacturers/ 2026-10-22T14:34:58Z NXTin health en In exceptional cases, hospitals and pharmacies will be allowed to purchase medicines directly from foreign manufacturers 2026-10-22T14:34:55Z Blog https://nxtin.health/2026/10/22/novartis-receives-european-commission-approval-for-cosentyx-in-polymyalgia-rheumatica/ 2026-10-22T14:26:40Z NXTin health en Novartis receives European Commission approval for Cosentyx® in polymyalgia rheumatica 2026-10-22T14:25:50Z Blog https://nxtin.health/2026/10/22/at-the-biophot-conference-participants-will-discuss-turning-science-into-globally-competitive-innovations/ 2026-10-22T06:54:52Z NXTin health en At the “BioPhoT” conference, participants will discuss how to turn scientific research into globally competitive innovations 2026-10-22T06:47:22Z Blog https://nxtin.health/2026/10/21/lumina-digital-twins-for-more-personalised-lung-cancer-care/ 2026-10-21T12:23:18Z NXTin health en LUMINA: digital twins for more personalised lung cancer care 2026-10-21T12:23:15Z Blog https://nxtin.health/2026/10/21/femmebiome-takes-major-step-towards-commercialisation-with-launch-of-moreme-pioneer-programme/ 2026-10-21T12:12:39Z NXTin health en FemmeBiome takes major step towards commercialisation with launch of MoreMe Pioneer programme 2026-10-21T12:12:36Z Blog https://nxtin.health/2026/10/21/the-missing-link-in-europes-life-science-battle-we-create-world-class-research-but-we-are-lagging-behind-in-commercialisation-and-global-scaling/ 2026-10-21T12:04:53Z NXTin health en The missing link in Europe's life science battle 2026-10-21T12:01:04Z Blog https://nxtin.health/2026/10/21/critical-raw-materials-securing-europes-supply-and-strategic-autonomy/ 2026-10-21T10:49:21Z NXTin health en Critical Raw Materials: securing Europe’s supply and strategic autonomy 2026-10-21T06:19:13Z Blog